Kyle Weant to Clinical Protocols
This is a "connection" page, showing publications Kyle Weant has written about Clinical Protocols.
Connection Strength
0.526
-
Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012 May; 32(5):433-40.
Score: 0.365
-
Pharmacy resident participation with a 24-hour multidisciplinary stroke response team. Am J Health Syst Pharm. 2010 Nov 15; 67(22):1901, 1905-7.
Score: 0.083
-
Evidence-based, multidisciplinary approach to the development of a crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. Ann Pharmacother. 2010 Mar; 44(3):447-55.
Score: 0.079